Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 214

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 214
---
     |     2023 |     | II - 2025   |
| Behzad Aghazadeh, Ph.D.        |     |  52 |     | Director                                      |     |     2021 |     | III - 2026  |
| Richard Maroun                 |     |  69 |     | Director                                      |     |     2021 |     | III - 2026  |
| Emma Reeve                     |     |  64 |     | Director                                      |     |     2021 |     | III - 2026  |

Caley Castelein, M.D.,has served on the board of directors of Aadi (formerly known as Aerpio Pharmaceuticals, Inc. through August 2021) since March 2017. Dr. Castelein is the Founder and has been a Managing Director for Kearny Venture Partners, a healthcare investment firm, since 2006. Dr. Castelein is also the Founder and has been the Managing Director for KVP Capital, an investment fund, since 2013. He has been a director for Tourmaline Bio (NASDAQ: TRML) since October 2023, and Newbridge Pharmaceuticals since March 2015. Previously, Dr. Castelein served on the board of directors of ViewRay, Inc., a medical device company, from 2008 to October 2023; Alivecor, a medical device company from April 2015 to March 2020; Boreal Genomics, a diagnostics company, from October 2010 to September 2021; Waterstone Pharmaceuticals, a pharmaceutical company from March 2015 to March 2018; Wellpartner, a pharmaceutical distribution solutions company, from March 2015 to November 2017; and Neos Therapeutics, a pharmaceutical company from March 2015 to July 2015. Dr. Castelein received his M.D. from University of California, San Francisco and his A.B. in Biology from Harvard University. We believe that Dr. Castelein is qualified to serve as a director based on his industry experience and service on multiple company boards. Neil Desai, Ph.D.,founded Aadi Sub in October 2011 and served as President, Chief Executive Officer, and a member of the board of directors of Aadi Sub from inception until the closing of the Reverse Merger in August 2021, at which time he became a member of our board of directors and our President and Chief